{"id":"https://openalex.org/W6980150476","doi":null,"title":"Barriers to Entry and Retention for Medications for Addiction Treatment for Opioid Use Disorders","display_name":"Barriers to Entry and Retention for Medications for Addiction Treatment for Opioid Use Disorders","publication_year":2022,"publication_date":"2022-06-29","ids":{"openalex":"https://openalex.org/W6980150476"},"language":"en","primary_location":{"id":"pmh:oai:digitalshowcase.lynchburg.edu:dmscjournal-2365","doi":null,"is_oa":false,"landing_page_url":"https://digitalshowcase.lynchburg.edu/dmscjournal/vol4/iss3/79","pdf_url":null,"source":{"id":"https://openalex.org/S4377196904","display_name":"Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I21978226","host_organization_name":"University of Lynchburg","host_organization_lineage":["https://openalex.org/I21978226"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"University of Lynchburg DMSc Doctoral Project Assignment Repository","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mohr, Meredith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mohr, Meredith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34618589,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.953000009059906},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9419999718666077},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/barriers-to-treatment","display_name":"barriers to treatment","score":0.7170000076293945},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-initiation","display_name":"treatment initiation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/stigma","display_name":"stigma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/insurance-coverage","display_name":"insurance coverage","score":0.9769999980926514},{"id":"https://openalex.org/keywords/transportation-barriers","display_name":"transportation barriers","score":0.7390000224113464},{"id":"https://openalex.org/keywords/legal-involvement","display_name":"legal involvement","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7336999773979187},{"id":"https://openalex.org/C3020148958","wikidata":"https://www.wikidata.org/wiki/Q1260022","display_name":"Addiction treatment","level":3,"score":0.6549999713897705},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6111999750137329},{"id":"https://openalex.org/C2909451232","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opiate Substitution Treatment","level":5,"score":0.5450999736785889},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5259000062942505},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.49869999289512634},{"id":"https://openalex.org/C169885649","wikidata":"https://www.wikidata.org/wiki/Q55190072","display_name":"Addiction medicine","level":3,"score":0.483599990606308},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.47679999470710754},{"id":"https://openalex.org/C2909816603","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid-Related Disorders","level":5,"score":0.4758000075817108},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.4551999866962433},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4205000102519989},{"id":"https://openalex.org/C2993816172","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid addiction","level":4,"score":0.37860000133514404},{"id":"https://openalex.org/C2986900798","wikidata":"https://www.wikidata.org/wiki/Q5308926","display_name":"Drug treatment","level":2,"score":0.3264000117778778},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32019999623298645},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.3142000138759613},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.3050000071525574},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.30399999022483826},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.29179999232292175},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.27799999713897705},{"id":"https://openalex.org/C160050368","wikidata":"https://www.wikidata.org/wiki/Q132453","display_name":"Developed country","level":3,"score":0.2775000035762787},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.26980000734329224},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.26489999890327454},{"id":"https://openalex.org/C2991912374","wikidata":"https://www.wikidata.org/wiki/Q400711","display_name":"Substance use","level":2,"score":0.26330000162124634},{"id":"https://openalex.org/C79736992","wikidata":"https://www.wikidata.org/wiki/Q7316676","display_name":"Retention rate","level":2,"score":0.2567000091075897}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:digitalshowcase.lynchburg.edu:dmscjournal-2365","doi":null,"is_oa":false,"landing_page_url":"https://digitalshowcase.lynchburg.edu/dmscjournal/vol4/iss3/79","pdf_url":null,"source":{"id":"https://openalex.org/S4377196904","display_name":"Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I21978226","host_organization_name":"University of Lynchburg","host_organization_lineage":["https://openalex.org/I21978226"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"University of Lynchburg DMSc Doctoral Project Assignment Repository","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2975633731","https://openalex.org/W2761082593","https://openalex.org/W3096940405","https://openalex.org/W4389179312","https://openalex.org/W4313129654","https://openalex.org/W7146999580","https://openalex.org/W2977169600","https://openalex.org/W4392200295","https://openalex.org/W4387539157","https://openalex.org/W4366548577"],"abstract_inverted_index":{"Opiate":[0],"use":[1],"disorders":[2],"(OUD)":[3],"are":[4,47],"a":[5],"major":[6],"and":[7,12,26,62,75,79],"increasing":[8],"cause":[9],"of":[10,43,64,73],"morbidity":[11],"mortality":[13],"in":[14,48],"the":[15,33,56],"United":[16],"States.":[17],"Medications":[18],"for":[19,37],"addiction":[20],"treatment":[21,49],"(MAT),":[22],"such":[23,66],"as":[24,67],"methadone":[25],"buprenorphine,":[27],"have":[28],"been":[29],"shown":[30],"to":[31,60,87],"be":[32],"most":[34,57],"effective":[35],"treatments":[36],"OUD,":[38],"but":[39],"only":[40],"ten":[41],"percent":[42],"people":[44],"with":[45],"OUD":[46],"using":[50],"these":[51,88],"medications.":[52],"This":[53,82],"paper":[54,83],"identifies":[55],"common":[58],"barriers":[59],"initiation":[61],"retention":[63],"MAT,":[65],"stigma,":[68],"poor":[69],"insurance":[70],"coverage,":[71],"lack":[72],"education":[74],"training,":[76],"limited":[77],"transportation,":[78],"legal":[80],"involvement.":[81],"also":[84],"suggests":[85],"solutions":[86],"problems.":[89]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}